Back
ESC Premium Access

Age-adjusted risk factors are independently associated with an increased risk of ischaemic stroke, transient ischaemic stroke and systemic embolism in the ETNA-AF-Europe registry

Session: Atrial fibrillation e-posters
Topic: Stroke in Atrial Fibrillation
Speaker: Professor R. De Caterina (Pisa, IT)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
26 presentations
2 followers

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Access
Abstract
Slides
Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Access
Abstract
Slides
Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Professor R. De Caterina, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Net clinical benefit of direct oral anticoagulants in very elderly and high bleeding risk patients with atrial fibrillation who are often excluded from oral anticoagulation therapy: a nationwide popul

27 August 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

ESC 365 is supported by

logo Novo Nordisk